InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Fox Christine. Director active across 1 company, notably Teva Pharmaceutical Industries Ltd. Cumulatively, 6 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €648k. History available since 14 November 2025. The latest transaction was disclosed on 14 November 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Christine Fox is a declarant linked to Teva Pharmaceutical Industries Ltd, where she holds the role of EVP, U.S. Commercial. She has 6 filings in total, and across the recent filings tracked, the only stated amount is a sale of EUR 647630, with the modal transaction nature listed as option exercise, over the period from 2024-11-21 to 2026-03-09.